Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Suoling Zhou"'
Autor:
Bert W. O'Malley, David M. Lonard, Jianming Xu, Yang Yu, Andrew Lu, Suoling Zhou, Jin Wang, Lei Wang, Fei Yan, Aarti D. Rohira
Table S2 lists the primer sequences used for amplification in ChIP qPCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1395d6cc3c03e858dc96d6e5c99da4b0
https://doi.org/10.1158/0008-5472.22414820
https://doi.org/10.1158/0008-5472.22414820
Autor:
Bert W. O'Malley, David M. Lonard, Jianming Xu, Yang Yu, Andrew Lu, Suoling Zhou, Jin Wang, Lei Wang, Fei Yan, Aarti D. Rohira
Figure S2 shows that treatment of breast cancer cells with SI-2 reduces SRCs protein expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3cc24519219adae9b31915805e9765
https://doi.org/10.1158/0008-5472.22414826
https://doi.org/10.1158/0008-5472.22414826
Autor:
Bert W. O'Malley, David M. Lonard, Jianming Xu, Yang Yu, Andrew Lu, Suoling Zhou, Jin Wang, Lei Wang, Fei Yan, Aarti D. Rohira
Tumor-initiating cells (TIC) represent cancer stem-like cell (CSC) subpopulations within tumors that are thought to give rise to recurrent cancer after therapy. Identifying key regulators of TIC/CSC maintenance is essential for the development of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62064bab6c56de54f70568c4aca4add7
https://doi.org/10.1158/0008-5472.c.6509084.v1
https://doi.org/10.1158/0008-5472.c.6509084.v1
Autor:
Jianming Xu, Zhou Songyang, Suoling Zhou, Paola Mussi, Ray-Chang Wu, Dan Liu, Li Qin, Yuhui Yuan
Supplementary Methods and Materials from Genetic Screening Reveals an Essential Role of p27kip1 in Restriction of Breast Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568a019a5be911f1be097e7058ad2c16
https://doi.org/10.1158/0008-5472.22368689
https://doi.org/10.1158/0008-5472.22368689
Autor:
Jianming Xu, Norman M. Greenberg, Jean Ching-Yi Tien, Lan Liao, Suoling Zhou, Arthur C-K. Chung
Supplementary Figures 1-3 from Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5848fee8eebf2e2dd3042ab9b5db8c45
https://doi.org/10.1158/0008-5472.22366578
https://doi.org/10.1158/0008-5472.22366578
Autor:
Jianming Xu, Zhou Songyang, Suoling Zhou, Paola Mussi, Ray-Chang Wu, Dan Liu, Li Qin, Yuhui Yuan
The genetic changes and mechanisms underlying the progression of estrogen-dependent breast cancers to estrogen-independent, antiestrogen-resistant, and metastatic breast cancers are unclear despite being a major problem in endocrine therapy. To ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885ca79a2d0fc846b71d3e355b6bc4b2
https://doi.org/10.1158/0008-5472.c.6496073.v1
https://doi.org/10.1158/0008-5472.c.6496073.v1
Autor:
Jianming Xu, Norman M. Greenberg, Jean Ching-Yi Tien, Lan Liao, Suoling Zhou, Arthur C-K. Chung
Although the amplified-in-breast cancer 1 (AIB1; SRC-3, ACTR, or NCoA3) was defined as a coactivator for androgen receptor (AR) by in vitro studies, its role in AR-mediated prostate development and prostate cancer remained unexplored. We report here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51faec3afa767baa54a29d469fee8182
https://doi.org/10.1158/0008-5472.c.6495207.v1
https://doi.org/10.1158/0008-5472.c.6495207.v1
Publikováno v:
International Journal of Biological Sciences, Vol 5, Iss 3, Pp 256-264 (2009)
The androgen and androgen receptor (AR)-regulated gene expression plays important roles in normal prostate and prostate cancer development, and AR transcriptional control of genes is mediated by transcriptional coactivators, including the three membe
Externí odkaz:
https://doaj.org/article/28d520917db84735be3a3079f4a6880c
Publikováno v:
International Journal of Biological Sciences, Vol 4, Iss 4, Pp 202-207 (2008)
The steroid receptor coactivator-3 (SRC-3), also known as AIB1, ACTR, p/CIP and NCOA3, is a transcriptional coactivator for nuclear receptors and certain other transcription factors. SRC-3 is widely expressed and plays important physiological functio
Externí odkaz:
https://doaj.org/article/732518aa302543b5a849a19657d5f23d
Autor:
Michael A. Mancini, Yang Yu, Jianming Xu, Lan Liao, Lei Wang, Chih Chao Hsu, Suoling Zhou, Dar Chone Chow, David M. Lonard, Bert W. O'Malley, Fabio Stossi, Timothy Palzkill, Fei Yan
Publikováno v:
Cancer Cell. 28(2):240-252
SummaryBy integrating growth pathways on which cancer cells rely, steroid receptor coactivators (SRC-1, SRC-2, and SRC-3) represent emerging targets in cancer therapeutics. High-throughput screening for SRC small molecule inhibitors (SMIs) uncovered